SCHEMBL872277

SCHEMBL872277

C=CCC(O)C(=C)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11649288 0.74
SCHEMBL5674658 0.74
SCHEMBL9241915 0.74
SCHEMBL246812 0.74
SCHEMBL9017751 0.74
SCHEMBL4079703 0.74
SCHEMBL31199 0.74 CYP2C19 (0.39)
SCHEMBL902141 0.74 CYP2C19 (0.39)
SCHEMBL28904230 0.72
SCHEMBL22341447 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 270 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111171684-A Preparation method of modified polyester enameled round copper wire 浙江五谷铜业股份有限公司 2020-05-19 CN claimed
US-7749970-B2 Application of an azalide antibiotic such as azithromycin INSITE VISION INCORPORATED (US) 2010-07-06 US claimed
US-20080161250-A1 Topical treatment or prevention of ocular infections DAWSON CHANDLER 2008-07-03 US claimed
EP-1212058-B1 TOPICAL TREATMENT FOR PREVENTION OF OCULAR INFECTIONS INSITE VISION INC (US) 2006-08-23 EP claimed
EP-1165058-B1 AZALIDE ANTIBIOTICS FOR THE TOPICAL TREATMENT OR PREVENTION OF OCULAR INFECTIONS INSITE VISION INC (US) 2005-05-25 EP claimed
US-20030206956-A1 Application of an azalide antibiotic such as azithromycin INSITE VISION INCORPORATED 2003-11-06 US claimed
JP-2002540147-A 2002-11-26 JP claimed
EP-1212058-A1 TOPICAL TREATMENT FOR PREVENTION OF OCULAR INFECTIONS INSITE VISION INCORPORATED (US) 2002-06-12 EP claimed
EP-1028707-B1 SUSTAINED RELEASE OPHTHALMIC COMPOSITIONS CONTAINING WATER SOLUBLE MEDICAMENTS INSITE VISION INC (US) 2002-02-20 EP claimed
EP-1165058-A2 USE OF AZALIDE ANTIBIOTICS FOR THE TOPICAL TREATMENT OR PREVENTION OF OCULAR INFECTIONS INSITE VISION INCORPORATED (US) 2002-01-02 EP claimed
US-6239113-B1 TOPICALLY APPLYING AN AQUEOUS POLYMERIC SUSPENSION OF AN AZALIDE ANTIBIOTIC SUCH AS AZITHROMYCIN INSITE VISION, INCORPORATED 2001-05-29 US claimed
WO-2001019366-A1 TOPICAL TREATMENT FOR PREVENTION OF OCULAR INFECTIONS INSITE VISION INCORPORATED (US) 2001-03-22 WO claimed
US-6159458-A Sustained release ophthalmic compositions containing water soluble medicaments INSITE VISION (US) 2000-12-12 US claimed
WO-2000057866-A2 USE OF AZALIDE ANTIBIOTICS FOR THE TOPICAL TREATMENT OR PREVENTION OF OCULAR INFECTIONS INSITE VISION INCORPORATED (US) 2000-10-05 WO claimed
EP-1028707-A1 SUSTAINED RELEASE OPHTHALMIC COMPOSITIONS CONTAINING WATER SOLUBLE MEDICAMENTS INSITE VISION INCORPORATED (US) 2000-08-23 EP claimed
WO-1999022713-A1 SUSTAINED RELEASE OPHTHALMIC COMPOSITIONS CONTAINING WATER SOLUBLE MEDICAMENTS INSITE VISION INCORPORATED (US) 1999-05-14 WO claimed
US-12458610-B2 Pharmaceutical composition for treating or preventing diabetic cataract KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION (KR) 2025-11-04 US disclosed
EP-4268843-B1 IMPROVED IL-6 ANTIBODIES F HOFFMANN LA ROCHE LTD (CH) 2025-09-03 EP disclosed
EP-0362321-A1 OPHTHALMIC SUSPENSIONS. INSITE VISION INC (US) 1990-04-11 EP disclosed
WO-1989006964-A1 OPHTHALMIC SUSPENSIONS INSITE VISION, INC. (US) 1989-08-10 WO disclosed